Governmental » FDA
FDA Abbreviations
Browse all acronyms and abbreviations related to the FDA terminology and jargon.
you just see All 4161 abbreviations related by the acronyms or terminology and jargon is FDA under the category Governmental
Browse All Abbreviation related to the Acronym FDA. All abbreviations on this page are (b)(4) means Freedom of Information Act Exemption 4, which protects from disclosure ôtrade secrets and commercial, 1932 means FDA form for veterinary adverse drug reaction, lack of effectiveness, product defect report--mandatory, 1932a means FDA form for veterinary adverse drug reaction, lack of effectiveness, product defect report--voluntary, 21 CFR Part 314 Subpart H means Subpart of Part 314 pertaining to accelerated approval of drugs, 2301 means FDA form for transmittal of periodic reports and promotional material for new animal drugs, 348 means FDA form for sponsored travel, 3500 means FDA form for voluntary reporting of adverse events, 3500A means FDA form for mandatory reporting of adverse events, 356V means FDA form for new animal drug appication, 3R means Recruitment, Relocation bonuses, and Retention allowances, 406B means Section of the FDA Modernization Act dealing with getting feedback from our stakeholders, 482 means FDA form for notice of inspection, 483 means FDA form used as a written notice of deficiencies found in inspections, 505(b)(2) means A new drug application that contains full reports of investigations of safety and effectiveness but , 510(k) means Food, Drug, and Cosmetic Act Section 501(k), Pre-Market Notification, 510(k) means Food, Drug, and Cosmetic Act Section 510(k), Pre-Market Notification, A-V means Arterio-Venous, A-VO2 means Arterio-Venous Oxygen, A/L means Annual Leave, A2LA means American Association for Laboratory Accreditation,
| Abbreviations | Definition | More |
|---|---|---|
| (b)(4) | Freedom of Information Act Exemption 4, which protects from disclosure ôtrade secrets and commercial. | (b)(4) |
| 1932 | FDA form for veterinary adverse drug reaction, lack of effectiveness, product defect report--mandatory. | 1932 |
| 1932a | FDA form for veterinary adverse drug reaction, lack of effectiveness, product defect report--voluntary. | 1932a |
| 21 CFR Part 314 Subpart H | Subpart of Part 314 pertaining to accelerated approval of drugs. | 21 CFR Part 314 Subpart H |
| 2301 | FDA form for transmittal of periodic reports and promotional material for new animal drugs. | 2301 |
| 348 | FDA form for sponsored travel. | 348 |
| 3500 | FDA form for voluntary reporting of adverse events. | 3500 |
| 3500A | FDA form for mandatory reporting of adverse events. | 3500A |
| 356V | FDA form for new animal drug appication. | 356V |
| 3R | Recruitment, Relocation bonuses, and Retention allowances. | 3R |
| 406B | Section of the FDA Modernization Act dealing with getting feedback from our stakeholders. | 406B |
| 482 | FDA form for notice of inspection. | 482 |
| 483 | FDA form used as a written notice of deficiencies found in inspections. | 483 |
| 505(b)(2) | A new drug application that contains full reports of investigations of safety and effectiveness but . | 505(b)(2) |
| 510(k) | Food, Drug, and Cosmetic Act Section 501(k), Pre-Market Notification. | 510(k) |
| 510(k) | Food, Drug, and Cosmetic Act Section 510(k), Pre-Market Notification. | 510(k) |
| A-V | Arterio-Venous. | A-V |
| A-VO2 | Arterio-Venous Oxygen. | A-VO2 |
| A/L | Annual Leave. | A/L |
| A2LA | American Association for Laboratory Accreditation. | A2LA |